50 phenotypes from 7 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Faddtm1.1Mpa/Faddtm1.1Mpa involves: BALB/cJ * C57BL/6 * SJL	embryonic lethality	J:167475
Faddtm1e.1(KOMP)Wtsi/Fadd+ C57BL/6N-Faddtm1e.1(KOMP)Wtsi/Ucd	abnormal uterus morphology	J:211773
	decreased lean body mass	J:211773
	increased total body fat amount	J:211773
Faddtm1e.1(KOMP)Wtsi/Faddtm1e.1(KOMP)Wtsi C57BL/6N-Faddtm1e.1(KOMP)Wtsi/Ucd	abnormal embryo size	J:211773
	abnormal neural tube closure	J:211773
	preweaning lethality, complete penetrance	J:211773
Faddtm1Mak/Faddtm1Mak either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)	abnormal myocardium layer morphology	J:46527
	decreased embryo size	J:46527
	decreased fibroblast apoptosis	J:46527
	embryonic growth retardation	J:46527
	embryonic lethality during organogenesis, complete penetrance	J:46527
	internal hemorrhage	J:46527
	thin myocardium	J:46527
	trabecula carnea hypoplasia	J:46527
Faddtm1Mpa/Faddtm1Mpa Mogtm1(cre)Gkl/Mog+ involves: C57BL/6 * SJL	abnormal oligodendrocyte apoptosis	J:167475
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:167475
	normal immune system phenotype	J:167475
	normal nervous system phenotype	J:167475
Faddtm1Mpa/Faddtm1Mpa Tg(Vil1-cre)997Gum/0 B6.Cg-Faddtm1Mpa Tg(Vil1-cre)997Gum	abnormal cecum morphology	J:175865
	abnormal colon morphology	J:175865
	abnormal enterocyte physiology	J:175865
	abnormal enterocyte proliferation	J:175865
	abnormal intestinal mucosa morphology	J:175865
	cecum inflammation	J:175865
	colitis	J:175865
	crypts of Lieberkuhn abscesses	J:175865
	decreased body weight	J:175865
	decreased Paneth cell number	J:175865
	diarrhea	J:175865
	increased enterocyte apoptosis	J:175865
	intestinal ulcer	J:175865
	postnatal lethality, incomplete penetrance	J:175865
Faddtm1Wnt/Faddtm1Wnt involves: 129S4/SvJae	decreased sensitivity to induced cell death	J:63946
	embryonic lethality, complete penetrance	J:46526
Faddtm1Wnt/Faddtm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Cd4-cre)1Cwi/? involves: 129S4/SvJae * C57BL/6 * DBA/2	decreased activated T cell number	J:113207
	decreased sensitivity to induced cell death	J:113207
	decreased single-positive T cell number	J:113207
	normal immune system phenotype	J:113207
	increased B cell number	J:113207
Faddtm1Wnt/Faddtm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Lck-cre)1Cwi/? involves: 129S4/SvJae	decreased activated T cell number	J:113207
	decreased sensitivity to induced cell death	J:113207
	decreased single-positive T cell number	J:113207
	normal immune system phenotype	J:113207
	increased B cell number	J:113207
Faddtm1Wnt/Faddtm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Mx1-cre)1Cgn/? involves: 129S4/SvJae * C57BL/6 * CBA	abnormal bone marrow cell morphology/development	J:168722
	abnormal erythrocyte morphology	J:168722
	decreased bone marrow cell number	J:168722
	spleen hypoplasia	J:168722
	thymus hypoplasia	J:168722
Faddtm2.1Wnt/Faddtm2.1Wnt Tg(Cd4-cre)1Cwi/? B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt	abnormal erythrocyte cell number	J:162312
	abnormal T cell proliferation	J:162312
	abnormal T cell subpopulation ratio	J:162312
	abnormal thymocyte apoptosis	J:162312
	enlarged lymph nodes	J:162312
	enlarged spleen	J:162312
	increased B cell number	J:162312
	increased susceptibility to parasitic infection	J:162312